期刊文献+

人外周血树突状细胞-乳腺癌细胞融合细胞 被引量:4

Scanning electron microscopy of fusion cells by dendritic cells in peripheral blood with human breast carcinoma cells
暂未订购
导出
摘要 目的:探讨树突状细胞-肿瘤细胞融合细胞的形态特性,为研制融合细胞疫苗提供形态学依据。方法:将免疫磁珠法分离的人外周血树突状细胞与人乳腺癌细胞株MCF7融合,瑞氏-姬姆萨染色观察;扫描电镜观察树突状细胞、融合细胞的表面超微结构。结果:树突状细胞与MCF7细胞接10:1比例融合后,一个乳腺癌细胞可以与一个或多个树突状细胞相融合;扫描电镜下可见分离的树突状细胞表面有突起,树突状细胞/MCF7融合细胞具两种亲代细胞的表面超微结构特点。结论:树突状细胞与人乳腺癌细胞融合后无明显的形态改变。 Objective:To study morphological features of the fusion cells and provide a morphological basis for producing fusion cell vaccine. Methods; Dendritic cells acquired by MACS from human peripheral blood were fused with human breast carcinoma cell line,MCF7. The morphological characteristics of dendritic cells, MCF7 cells and dendritic cell/MCF7 cell were observed with Wright-Giemsa staining and scanning electron microscopy(SEM). Results: A MCF7 cell could fuse with one or more dendritic cells. Process of dendritic cells could be observed by SEM. The fusion cells retained its parental cells' surface ultrastructural feature. Conclusion:The morphological characteristics of the fusion cells of dendritic cells with MCF7 cells do not alter compared with its parental cells.
出处 《解剖学杂志》 CAS CSCD 北大核心 2003年第2期105-108,共4页 Chinese Journal of Anatomy
基金 国家自然科学基金(39970380)
关键词 乳腺癌细胞 树突状细胞 融合细胞 疫苗 免疫磁珠法 瑞氏-姬姆萨染色法 扫描电镜 dendritic cell breast carcinoma cell fusion cell
  • 相关文献

同被引文献34

  • 1张坤,高朋芬,余佩武,饶云,周立新.SGC7901胃癌细胞-树突状细胞融合疫苗生物学特性的研究[J].中华普通外科杂志,2005,20(6):362-364. 被引量:2
  • 2曲鹏,唐军民.树突状细胞—郎格罕氏细胞与抗肿瘤[J].解剖科学进展,1997,3(1):13-18. 被引量:1
  • 3关心,彭吉润,冷希圣.人树突状细胞与肝癌细胞系HLE融合细胞的构建[J].中华肿瘤杂志,2005,27(8):465-467. 被引量:14
  • 4Bancheraeu J,Steinman RM.Dendritic cell and the control of immunity.Nature,1998,392:245-252.
  • 5Nestle FO,Alijagic S,Gilliet M,et al.Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells.Nat Med,1998,4:328-332.
  • 6Laurence Lesagnard,Pascal Mettens,Anne-Marie Verheyden,et al.Dendritic cells fused with mastocytoma cells elictit therapeutic antitumor immunity.Int.J.Cancer,1998,76:250-258.
  • 7Takagi Y,Kikuchi T,Niimura M,et al.Anti-tumor effects of dendritic and tumor cell fusions are not dependent on expression of MHC class I and II by dendritic cells.Cancer Lett,2004,15;213(1):49-55.
  • 8Lundqvist A,Palmborg A,Bidla G,et al.Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses.Med Oncol,2004,21(2):155-65.
  • 9Koido S,Ohana M,Liu C,et al.Dendritic cells fused with human cancer cells:morphology,antigen expression,and T cell stimulation.Clin Immunol,2004,113(3):261-269.
  • 10Bancheraeu J,Steinman RM.Dendritic cell and the control of immunity.Nature,1998,392:245-252.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部